Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial

NCT02406781 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

129

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Combination of MK3475 with Metronomic CP
DRUG: Combination of MK3475 with Metronomic CP and G100

Sponsor

Institut Bergonié

Collaborators

[object Object]
[object Object]
[object Object]